AIMS: To describe results of melanoma brain metastases (BM) treated with whole-brain radiation (WBRT). METHODS: Retrospective review of patients with melanoma BM treated with WBRT divided into two groups based on the timing of WBRT (at BM diagnosis or recurrence). RESULTS: We identified 61 patients with melanoma BM who received WBRT. For the group treated at diagnosis (n = 39): median overall survival was 3 months; best radiographic response included one partial response, ten stable disease, 18 progressive disease, and ten no follow-up imaging. For the group treated at recurrence (n = 22): median overall survival was 3 months; best radiographic response was three partial response, four stable disease, eight progressive disease, and seven no follow-up imaging. CONCLUSION: WBRT activity was limited; however, its role in symptom palliation is unclear.
AIMS: To describe results of melanoma brain metastases (BM) treated with whole-brain radiation (WBRT). METHODS: Retrospective review of patients with melanoma BM treated with WBRT divided into two groups based on the timing of WBRT (at BM diagnosis or recurrence). RESULTS: We identified 61 patients with melanoma BM who received WBRT. For the group treated at diagnosis (n = 39): median overall survival was 3 months; best radiographic response included one partial response, ten stable disease, 18 progressive disease, and ten no follow-up imaging. For the group treated at recurrence (n = 22): median overall survival was 3 months; best radiographic response was three partial response, four stable disease, eight progressive disease, and seven no follow-up imaging. CONCLUSION: WBRT activity was limited; however, its role in symptom palliation is unclear.
Authors: D F McDermott; J W Mier; D P Lawrence; M R van den Brink; M A Clancy; K M Rubin; M B Atkins Journal: Clin Cancer Res Date: 2000-06 Impact factor: 12.531
Authors: Cameron Brennan; T Jonathan Yang; Patrick Hilden; Zhigang Zhang; Kelvin Chan; Yoshiya Yamada; Timothy A Chan; Stella C Lymberis; Ashwatha Narayana; Viviane Tabar; Philip H Gutin; Åse Ballangrud; Eric Lis; Kathryn Beal Journal: Int J Radiat Oncol Biol Phys Date: 2014-01-01 Impact factor: 7.038
Authors: K M Fife; M H Colman; G N Stevens; I C Firth; D Moon; K F Shannon; R Harman; K Petersen-Schaefer; A C Zacest; M Besser; G W Milton; W H McCarthy; J F Thompson Journal: J Clin Oncol Date: 2004-04-01 Impact factor: 44.544
Authors: Henrik Hauswald; Jan-Oliver Dittmar; Daniel Habermehl; Stefan Rieken; Florian Sterzing; Jürgen Debus; Stephanie E Combs Journal: Radiat Oncol Date: 2012-08-02 Impact factor: 3.481
Authors: Cara L Haymaker; DaeWon Kim; Marc Uemura; Luis M Vence; Ann Phillip; Natalie McQuail; Paul D Brown; Irina Fernandez; Courtney W Hudgens; Caitlin Creasy; Wen-Jen Hwu; Padmanee Sharma; Michael T Tetzlaff; James P Allison; Patrick Hwu; Chantale Bernatchez; Adi Diab Journal: Cancer Immunol Res Date: 2017-01-06 Impact factor: 11.151
Authors: Justine V Cohen; Hussain Tawbi; Kim A Margolin; Ravi Amravadi; Marcus Bosenberg; Priscilla K Brastianos; Veronica L Chiang; John de Groot; Isabella C Glitza; Meenhard Herlyn; Sheri L Holmen; Lucia B Jilaveanu; Andrew Lassman; Stergios Moschos; Michael A Postow; Reena Thomas; John A Tsiouris; Patrick Wen; Richard M White; Timothy Turnham; Michael A Davies; Harriet M Kluger Journal: Pigment Cell Melanoma Res Date: 2016-10-22 Impact factor: 4.693